IP Verse

Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders - EP3300601

PATENT ANALYSIS

Patent Details

Grant Date
Jan 12, 2022
Company
CELATOR PHARMACEUTICALS, INC.
Oppositions

GENERICS [UK] LIMITED

SANDOZ AG

STADA ARZNEIMITTEL AG

More patents of Celator Pharmaceuticals, Inc.

EP3300601

EP2768484

EP2120568

Want to monitor this patent?

Feel free to send us a message here and we will get back to you